CODY DAVIES: Open Payments
NPI 1417377870 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 14 payments from 8 companies in 2025. Trend: 2023 $16 · 2024 $116 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $168 |
| Amgen Inc. | 1 | $109 |
| Insulet Corporation | 2 | $104 |
| Tandem Diabetes Care, Inc. | 3 | $98 |
| Abbott Laboratories | 2 | $47 |
| Novo Nordisk Inc | 2 | $40 |
| Dexcom, Inc. | 1 | $20 |
| Ascendis Pharma Endocrinology Inc | 1 | $19 |
Products named: MINIMED 780G, TEPEZZA, Omnipod, t:slim X2 Insulin Pump with Control-IQ, FREESTYLE LIBRE 3, Wegovy, Dexcom G6 Transmitter, Yorvipath.
Industry payments across ID — which companies pay providers there.
